Unadjusted and adjusted factors associated with all-cause mortality among HIV-positive injection drug users initiating highly active antiretroviral therapy in British Columbia, between June 1998 and Sept 2011 (n = 254).

1<p>Hazard Ratio</p>2<p>95% Confidence Interval</p>3<p>Adjusted Hazard Ratio</p>4<p>Highly active antiretroviral therapy</p>5<p>Protease Inhibitor</p>6<p>Within the last 12 months of interview</p

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by hunger status.

<p>Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by hunger status.</p

Baseline characteristics among HIV-positive injection drug users initiating antiretroviral therapy across British Columbia, by food security status, between June 1998 and Sept 2011 (n = 254).

1<p>Inter-quartile range</p>2<p>Highly active antiretroviral therapy use</p>3<p>Protease Inhibitor-based regimen</p>4<p>Within last 12 months of interview</p

Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by food security status.

<p>Adjusted cumulative incidence of all-cause mortality among HIV-positive injection drug users initiating antiretroviral therapy in British Columbia, stratified by food security status.</p

Adjusted odds ratios predicting attrition between stages of the 2011 HIV cascade of care based on sex, age, transmission risk category and regional health authority for British Columbia residents diagnosed with HIV before 2011.

<p>aOR  =  adjusted odds ratio; CI  =  confidence interval; Risk group categorized as men who have sex with men (MSM), having a history of injection drug use (IDU), both MSM and IDU (MSM/IDU), heterosexual (hetero), or other (blood transfusion or perinatal exposure or unknown risk group (i.e., risk factor not requested or identified)).</p><p>Adjusted odds ratios predicting attrition between stages of the 2011 HIV cascade of care based on sex, age, transmission risk category and regional health authority for British Columbia residents diagnosed with HIV before 2011.</p

Estimated HIV cascade of care by risk category in 2011 for British Columbia.

<p>*MSM  =  men who have sex men, IDU  =  history of injection drug use, MSM/IDU  =  both MSM and IDU, Other  =  blood transfusion or perinatal exposure or unknown risk group (i.e., risk factor not requested or identified).</p

Estimated HIV cascade of care by age category and sex in 2011 for British Columbia.

<p>*Age is defined as age as of January 1^st, 2011. There were 39 HIV-diagnosed individuals with missing gender and age information; none of these individuals were linked to HIV care.</p

Estimated HIV cascade of care by Regional Health Authority in 2011 for British Columbia.

<p>*There were 148 HIV-diagnosed individuals with missing Regional Health Authority information. Of these, 106 were linked to care; 51 of those linked to HIV care were retained in care; 24 of those retained in care were on antiretrovirals (ARVs) and 14 of those on ARV were suppressed.</p

Estimated HIV cascade of care overall and by sex in 2011 for British Columbia.

<p>*There were 39 HIV-diagnosed individuals with missing sex information; none of these individuals were linked to HIV care.</p

Number of observations per plasma HIV-1 RNA levels (pVL) between the lower limit of quantification of each assay and 1000 copies/mL.

<p>Period 1 (Amplicor): 08/03/2000-01/02/2008; Period 2 (Taqman v1.0): 07/01/2010-07/03/2012; Period 3 (Taqman v2.0): 08/03/2012-30/06/2014.</p